Peter Luo is the founder of Adagene. Adagene has raised $150M in total funding. Latest round: Series D. Backed by General Atlantic.
Peter Luo is the Co-founder and Chief Executive Officer of Adagene, a clinical-stage oncology immunotherapy company. Adagene focuses on developing innovative treatments using its Dynamic Precision Library platform. The company has raised over $150 million from private financings since 2014, including a $69 million Series D round led by General Atlantic in 2020.
Full founder directory · Investor directory · Company funding database · Fundraising library